US Stock MarketDetailed Quotes
AVBP ArriVent BioPharma
- 18.740
- +0.410+2.24%
Trading Jun 5 12:04 ET
627.67MMarket Cap-8403P/E (TTM)
18.980High18.420Low6.67KVolume18.650Open18.330Pre Close124.91KTurnover0.08%Turnover RatioLossP/E (Static)33.49MShares25.95052wk High1.98P/B156.17MFloat Cap14.35052wk Low--Dividend TTM8.33MShs Float25.950Historical High--Div YieldTTM3.06%Amplitude14.350Historical Low18.732Avg Price1Lot Size
About ArriVent BioPharma Company
Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company. It focuses on identifying, licensing and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
Company Profile
SymbolAVBP
Company NameArriVent BioPharma
Listing DateJan 26, 2024
Issue Price18.00
Founded2021
CEODr. Zhengbin Yao, PhD
MarketNASDAQ
Employees40
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address18 Campus Boulevard,Suite 100
CityNewtown Square
ProvincePennsylvania
CountryUnited States of America
Zip Code19073
Phone1-628-277-4836
Websitehttp://www.arrivent.com
Company Executives
- Name
- Position
- Salary
- Dr. Zhengbin Yao, PhD
- Chairman of Board and Chief Executive Officer
- 1.19M
- Robin LaChapelle, M.D.
- Chief Operating Officer
- 960.99K
- Winston Kung, M.B.A.
- Chief Financial Officer and Treasurer
- --
- Dr. Stuart Lutzker, M.D.,PhD
- Director and President, Research and Development
- 828.75K
- Dr. Carl L. Gordon, C.F.A.,PhD
- Director
- --
- Christian W. Nolet, C.P.A.
- Independent Director
- 79.28K
- Dr. Bahija Jallal, PhD
- Independent Director
- 17.80K
- Dr. James I. Healy, M.D.,PhD
- Independent Director
- --
- Dr. John A. Hohneker, M.D.
- Independent Director
- --
- Kristine Peterson
- Independent Director
- --
- James Paul Kastenmayer, J.D.,PhD
- General Counsel and Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
